CeriBell, Inc.
$17.18
-1.8%CeriBell, Inc. develops AI based point-of-care electroencephalography (EEG) technology for the detection and treatment of neurological conditions. The company develops Ceribell System, a novel, point-of-care EEG platform to address the unmet needs of patients in the acute care setting. It also offers EEG disposable headbands; and pocket-sized battery-operated recorders. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. The company was incorporated in 2014 and is based in Sunnyvale, California.
At a Glance
Live SnapshotIntrinsic Alpha Methodology
Thesis Lenses
Signal
Medium confidenceValuation multiple is compressed (P/E -11.8).
Valuation inputs: P/E -11.8, earnings yield N/A, momentum -1.8%.
If multiples stay elevated while momentum fades, downside repricing risk rises.
Driver
High confidenceReturn profile is soft (ROE -34.4%, ROIC -32.9%).
Profitability stack: net margin -60.0%, ROE -34.4%, ROIC -32.9%.
Quality deterioration often appears in margins before it shows up in headline EPS.
Risk
High confidenceRisk profile is balanced but has notable pressure points to monitor.
Risk factors: liabilities/assets +20.7%, momentum -1.8%, net margin -60.0%.
Higher leverage with weak momentum and thin margins can amplify drawdown severity.
CeriBell, Inc. Market vs Earnings Trajectory
Loading price and EPS data...
CeriBell, Inc. Fair Value Envelope
CeriBell, Inc. Profit Bridge
Profitability Analysis
Gross Margin
Exceptional pricing power and cost management. The company retains over half of revenue after direct costs.
Operating Margin
Operating losses indicate the core business is unprofitable. Requires restructuring or revenue growth.
Net Profit Margin
Net losses indicate the company is burning cash. Sustainability depends on path to profitability.
Profitability Insight
Margin squeeze alert: Healthy gross margins but weak operating margins suggest excessive operating expenses. Cost optimization could unlock significant value.
CeriBell, Inc. Cash Conversion Engine
Cash Flow Quality Analysis
FCF Conversion Rate
Moderate conversion rate. Some gap between earnings and cash flow may warrant investigation into working capital or non-cash items.
CapEx Intensity
Asset-light business model. Low capital requirements leave more cash available for shareholders and growth investments.
FCF Growth Trend
Declining FCF warrants attention. Investigate whether due to temporary factors or fundamental deterioration.
Working Capital Impact
Working capital inflow boosted cash flow. Efficient management of receivables, inventory, and payables contributing positively.
CeriBell, Inc. Funding & Solvency Profile
Financial Health Analysis
Current Ratio
Excellent liquidity position. The company can easily cover its short-term obligations with substantial cushion.
Debt-to-Equity Ratio
Conservative capital structure. The company relies primarily on equity financing, indicating low financial risk.
Working Capital
Strong working capital position provides significant operational flexibility and financial cushion.
Asset Composition
Asset-light business model with high liquidity. Majority of assets are easily convertible to cash.
Financial Health Insight
Strong financial foundation: Excellent liquidity combined with conservative leverage suggests the company is well-positioned to weather economic uncertainties and fund growth opportunities.
CeriBell, Inc. Street Expectations Map
Wall Street analysts project that CBLL stock may rise significantly over the coming 12 months. The consensus 1-year price target stands at 27.50, with estimates ranging from a low of 25.00 to a high of 30.00.
The consensus 1-year price target stands at 27.50, with estimates ranging from a low of 25.00 to a high of 30.00.
Analyst Consensus Analysis
Upside Potential
Substantial upside potential. Analysts see significant value gap, suggesting the stock may be materially undervalued at current levels.
Analyst Agreement
High analyst agreement. Narrow target range indicates strong consensus on valuation, suggesting clear investment thesis and predictable outlook.
Analyst Conviction
Strong buy conviction: High upside with tight consensus suggests compelling investment opportunity backed by analyst confidence.
Market Sentiment Insight
Rare opportunity: Exceptional upside potential with strong analyst consensus creates a compelling setup. The combination of significant price target premium and tight agreement suggests high-conviction undervaluation that may attract institutional capital.
CeriBell, Inc. Insider Positioning
During the last 12 months, insiders have purchased $86K and sold $8.19M worth of CBLL shares, resulting in $8.11M of net selling activity.
3 Months
0
0.00
40.6K
747.46K
-747K
-$747K
3-6 Months
3.0K
55.24K
263.9K
5.48M
-5.4M
-$5.43M
6-9 Months
6.6K
31.09K
125.2K
1.96M
-1.9M
-$1.93M
9-12 Months
0
0.00
0
0.00
+0
+$0
Top Buyers
Woo Raymond
Officer: Chief Technology Officer
$86K
Top Sellers
Chao Xingjuan
Director, Officer: President And Ceo
$4.29M
Parvizi Josef
Director
$2.12M
Burke William W
Director
$506K
Blumberg Scott
Officer: Chief Financial Officer
$455K
Woo Raymond
Officer: Chief Technology Officer
$442K
Insider Activity Analysis
Net Insider Sentiment
Strong bearish signal with $8.11M net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.
Buy/Sell Ratio
Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.
Recent Trend (3 Months)
Heavy recent selling activity. Recent insider sales notably exceed purchases—may warrant investigation into company developments.
Insider Participation
5 insider sellers vs. 1 buyers. Widespread selling across multiple insiders may signal concerns.
Insider Activity Insight
Multiple red flags: Heavy selling, numerous sellers, and continued recent selling create a concerning pattern. Investigate fundamental drivers and consider whether company guidance or industry conditions have deteriorated.
No Dividend Yield Data
CBLL has not reported any dividend yield values in the available annual periods.
cbll Dividend History
Learning Layer
Related Guides
Build conviction on CBLL by pairing this stock hub with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.